Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
Cash Flows From Operating Activities | |||||
Net Income | 1,834,000 | 5,668,000 | 4,563,000 | 3,034,000 | 1,552,000 |
Depreciation Amortization | 412,000 | 1,605,000 | 1,241,000 | 804,000 | 412,000 |
Income taxes - deferred | N/A | -106,000 | N/A | N/A | N/A |
Accounts receivable | -152,000 | -159,000 | -420,000 | -372,000 | -240,000 |
Other Working Capital | -311,000 | 1,592,000 | 264,000 | 88,000 | -304,000 |
Other Operating Activity | 152,000 | 264,000 | 420,000 | 372,000 | 240,000 |
Operating Cash Flow | $1,935,000 | $8,864,000 | $6,068,000 | $3,926,000 | $1,660,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -332,000 | -1,568,000 | -824,000 | -518,000 | -242,000 |
Net Acquisitions | -28,000 | -225,000 | -44,000 | -17,000 | -17,000 |
Purchase Of Investment | -1,689,000 | -8,188,000 | -6,453,000 | -4,430,000 | -1,631,000 |
Sale Of Investment | 2,023,000 | 5,967,000 | 5,288,000 | 3,649,000 | 1,553,000 |
Other Investing Activity | -58,000 | -79,000 | -54,000 | -69,000 | -77,000 |
Investing Cash Flow | $-84,000 | $-4,093,000 | $-2,087,000 | $-1,385,000 | $-414,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 272,000 | 338,000 | 235,000 | 187,000 | 116,000 |
Debt Issued | 17,000 | 14,000 | 13,000 | 10,000 | 4,000 |
Debt Repayment | -12,000 | -391,000 | -275,000 | -20,000 | -19,000 |
Common Stock Issued | 164,000 | 514,000 | 399,000 | 294,000 | 96,000 |
Common Stock Repurchased | -1,899,000 | -2,570,000 | -1,031,000 | -629,000 | -257,000 |
Dividend Paid | -549,000 | -2,047,000 | -1,498,000 | -950,000 | -447,000 |
Other Financing Activity | -156,000 | -1,109,000 | -1,033,000 | -938,000 | -645,000 |
Financing Cash Flow | $-2,163,000 | $-5,251,000 | $-3,190,000 | $-2,046,000 | $-1,152,000 |
Exchange Rate Effect | -9,000 | -40,000 | -3,000 | -51,000 | -32,000 |
Beginning Cash Position | 3,758,000 | 4,278,000 | 4,278,000 | 4,278,000 | 4,278,000 |
End Cash Position | 3,437,000 | 3,758,000 | 5,066,000 | 4,722,000 | 4,340,000 |
Net Cash Flow | $-321,000 | $-520,000 | $788,000 | $444,000 | $62,000 |
Free Cash Flow | |||||
Operating Cash Flow | 1,935,000 | 8,864,000 | 6,068,000 | 3,926,000 | 1,660,000 |
Capital Expenditure | -350,000 | -1,731,000 | -978,000 | -571,000 | -271,000 |
Free Cash Flow | 1,585,000 | 7,133,000 | 5,090,000 | 3,355,000 | 1,389,000 |